Signals
Business Insider
Signals
ABC
An Australian drug that melts away cancer in some stage four patients is given fast-track approval in the United States, but Australian patients cannot yet access it.
Signals
BBC
An immunotherapy drug is described as a potential "game changer" in promising trial results on advanced cancers.
Signals
Fox News
Early trials of a potential cancer treatment in which white blood cells are modified to target certain types of the disease have been an "extraordinary" success, scientists said Monday.
Signals
Wired
CRISPR proteins used with a process that amplifies RNA could be used to detect cancer cells
Signals
University of Geneva
Signals
Digital Journal
As Digital Journal has recently reported Microsoft has recently launched Healthcare NeXT, which is a cloud-based, artificial intelligence and research
Signals
SF Gate
A recent Stanford cancer study that cured 97 percent of mice from tumors has now moved on...
Signals
The Guardian
Blood tests called liquid biopsies show signs of finding cancers at an early stage
Signals
The Guardian
Trial on people with form of disease that killed Tessa Jowell remarkably promising
Signals
Popular Mechanics
Microsoft and the giants of cancer research are proving that big data is a mighty weapon.
Signals
Drug Target Review
An experimental cancer vaccine that boosts the immune system's ability to fight cancers could work in tandem with other cancer therapies
Signals
The Age
Thanks to world-leading vaccine and screening programs, cervical cancer could be almost unheard of in Australia in coming decades, new research has revealed.
Signals
Science Magazine
Modern update of once-controversial approach helps a handful of patients
Signals
New Atlas
Promising early results are in from a phase 1 clinical trial into a new cancer vaccine designed to stimulate the immune system into attacking certain cancers known to overexpress a specific protein.
Signals
Medicalxpress
Signals
Labiotech
New approaches to tame the immune system in the fight against cancer are getting us closer to a future where cancer becomes a curable disease. I spoke with experts in the field to gather a realistic overview of the potential of four of these promising new cancer treatments.
Signals
The Guardian
Revolutionary work on the body’s immune system and a host of new drug trials mean that beating cancer may be achievable
Signals
Business Insider
US scientists recently discovered a genetic "kill code" in our cells that could theoretically be used to treat cancer without chemotherapy.
Signals
Science Alert
Researchers have developed a test that could be used to diagnose all cancers. It is based on a unique DNA signature that appears to be common across cancer types.
Signals
Fierce Biotech
Regeneron’s CD20xCD3 bispecific antibody has achieved an 80% complete response rate in a small trial of patients with relapsed or refractory follicular lymphoma. The strong early signs of efficacy led Regeneron to target a 2019 start date for a potentially registrational phase 2 study.
Signals
Business Insider
The FDA just approved a new cancer treatment in an unconventional way: not by tumor type, but rather by the genetic mutation the drug targets.
Signals
QMUL
Signals
Nature
Cancer recurrence after surgical resection remains a significant cause of treatment failure. Here, we have developed an in situ formed immunotherapeutic bioresponsive gel that controls both local tumour recurrence after surgery and development of distant tumours. Briefly, calcium carbonate nanoparticles pre-loaded with the anti-CD47 antibody are encapsulated in the fibrin gel and scavenge H+ in th
Signals
University of Northwestern
Fourth study published over two-year span that analyzes key leukemia protein
Signals
Pharmafile
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.
Signals
NCBI
Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, type 1 (HSV-1), which can be administered intralesionally in patients with stage IIIB/C-IVM1a unresectable melanoma (EMA label). The phase 3 OPTiM registration study showed an overall response rate (ORR) of 26%. Since December 2016 …
Signals
Science Daily
Signals
CNBC
The treatment "has broad implications for multiple types of cancer," said lead author Dr. Joshua Brody.
Signals
Eurekalert
A new strategy for drug development can be used to produce targeted therapies against a variety of diseases.
Signals
Eurekalert
Enhancing cancer treatment is a 'major priority' for the UK public, which also thinks that the NHS needs more resources to provide 'excellent cancer care,' finds a new national survey led by UCL.
Signals
The Atlantic
Researchers are eager to leave behind the brutal side effects of chemotherapy and radiation.
Signals
Eurekalert
A stealthy new drug-delivery system disguises chemotherapeutics as fat in order to outsmart, penetrate and destroy tumors. Thinking the drugs are tasty fats, tumors invite the drug inside. Once there, the targeted drug activates, immediately suppressing tumor growth.
Signals
Medical Daily
This article was removed because it did not meet Medical Daily's editorial standards.
Signals
The Telegraph
A drug that can slow down the progression of Alzheimer’s disease has finally been found, scientists have announced.
Signals
The New York Times
Breakthrough treatments for lung cancer and melanoma have driven down cancer mortality overall — and from 2016 to 2017 spurred the largest-ever decline.
Signals
The Telegraph
A new type of immune cell which kills most cancers has been discovered by accident by British scientists, in a finding which could herald a major breakthrough in treatment.
Signals
The Guardian
System uses machine learning to offer new way to screen for hard to detect cancers
Signals
Wired
Researchers didn’t know if it would work, but they had little to lose when they tried a new drug known as a CAR-T—a living cell reprogrammed to recognize and kill leukemia—on a dying 6-year-old.
Signals
https://www.scientificamerican.com/article/experimental-blood-test-detects-cancer-up-to-four-years-before-symptoms-appear/
The assay looks for stomach, esophageal, colorectal, lung and liver malignancies
Signals
Wired
Carbon ion radiation therapy is being used to blast tumors all over the world. Just not in the country that invented it.
Signals
CBS
The artificial intelligence we see in daily life is just a fraction of its vast potential. Already it's making strides in cancer care
Signals
STV News
Aberdeen University researchers made the discovery during pre-clinical trials.
Signals
NIH
An AI algorithm outperformed other screening methods in identifying cervical precancer. The approach could be especially valuable in low-resource settings.
Signals
Annals of Oncology
Early cancer detection could identify tumors at a time when outcomes are superior
and treatment is less morbid. This prospective case-control sub-study (from NCT02889978
and NCT03085888) assessed the performance of targeted methylation analysis of circulating
cell-free DNA (cfDNA) to detect and localize multiple cancer types across all stages
at high specificity.
and treatment is less morbid. This prospective case-control sub-study (from NCT02889978
and NCT03085888) assessed the performance of targeted methylation analysis of circulating
cell-free DNA (cfDNA) to detect and localize multiple cancer types across all stages
at high specificity.
Signals
NIH
Special section on adults ages 20 to 49 shows higher cancer incidence and mortality for women than men.
Signals
Healthfoodis
Seneca Valley virus, named Senecavirus, impacts cows and pigs. Discovered to be capable to uniquely attack human cancer tissues.
Signals
Frontiers
Mast cell tumor (MCT) is the most common cutaneous neoplasm in dogs and wide surgical resection is the current first-line treatment. However, recurrence is common and often requires more specialist and expensive therapies. Tigilanol tiglate is a novel small molecule drug delivered by intratumoral injection that is currently under development to provide a new option for treating MCT. The aim of thi
Signals
MedicalXpress
Signals
Asia Times
Chinese scientists claim they have developed an infrared light-based, remotely-controlled gene-editing tool that can target and kill cancer cells with
Signals
CNA
SINGAPORE: Singapore scientists have discovered a new antibody drug that could potentially be used as an alternative for chemotherapy in ...
Signals
Ark Invest
Liquid biopsies could be the reason that next generation sequencing volumes will scale from 2.4 million in 2018 to 100 million genome-equivalents per year.
Signals
University of Utah Health
University of Utah Health investigators have identified a previously unrecognized characteristic of a mysterious vaping-related respiratory illness that could allow doctors to definitively diagnose the nascent syndrome more quickly and provide clues into causes of the condition.
Signals
AACR
Signals
New Atlas
A safer and less invasive treatment option for prostate cancer could soon be on the table, with a novel MRI-guided ultrasound technique eliminating significant cancers in 80 percent of subjects in a year-long study.
Signals
Israel21c
Israeli breakthrough study shows 90% reduction of pancreatic cancer cells in mice after treatment with a molecule named PJ34.
Signals
New Atlas
Radiation therapy is currently our best shot at treating cancer, but healthy cells often become unfortunate collateral damage. New research shows how the treatment can be made safer by reducing the time involved from weeks to seconds.
Signals
YouTube - a16z
We are at the beginning of a new era for how we treat one of humankind’s oldest and worst foes—cancer. In this talk, Jonathan Lim, CEO and cofounder of Erasc...
Signals
YouTube - ARK Invest
Today's guest is Charles Graeber (@charlesgraeber), author of the book The Breakthrough: Immunotherapy and the Race to Cure Cancer. Charles tells us about th...
Signals
YouTube - Big Think
Making cancer as harmless as the common coldNew videos DAILY: https://bigth.inkJoin Big Think Edge for exclusive video lessons from top thinkers and doers: h...
Signals
Charlie Rose
On breakthroughs in cancer treatment, with Drs. Bill Nelson, Louise Perkins, and Neil Segal, and researcher Tom Marsilje.
Signals
Stanford University
Stanford researchers have developed synthetic proteins that can rewire cancer cells in a lab dish by co-opting critical disease-associated pathways.
Signals
Nature
The Zero Childhood Cancer Program is a precision medicine program to benefit children with poor-outcome, rare, relapsed or refractory cancer. Using tumor and germline whole genome sequencing (WGS) and RNA sequencing (RNAseq) across 252 tumors from high-risk pediatric patients with cancer, we identified 968 reportable molecular aberrations (39.9% in WGS and RNAseq, 35.1% in WGS only and 25.0% in RN
Signals
Digital Health
The Government has launched a review to explore how data and technology can deliver a new era of intelligent, predictive and personalised NHS health checks.
Signals
CNET
Rapidly cooling patients could buy surgeons extra time to repair traumatic injuries.
